Cooled ThermoTherapy uses targeted microwave energy combined with a unique cooling mechanism to provide safe, effective and lasting relief from benign prostatic hyperplasia (BPH) symptoms. BPH, also known as enlarged prostate disease, is a non-cancerous condition that can make urination difficult or painful and is common in men over the age of 50.
“We look forward to working with the researchers at Rensselaer Polytechnic Institute and the scientific and engineering team at ProUroCare,” said David Montecalvo, Urologix vice president of product development and operations.
“If successful, we will be able to provide accurate discrete temperature measurements at multiple points in the prostate. This information will allow our treating physicians to view an image of the patients’ prostate during the procedure, showing the heating effect and associated tissue necrosis resulting from our Cooled ThermoTherapy treatment in real-time.”